(Q34604677)

3 August 2017

1 reference

title

Sialosyl-galactose: a common denominator of Guillain-Barré and related disorders? (English)

1 reference

3 August 2017

main subject

Guillain–Barré syndrome

0 references

author name string

Anthony P Moran

series ordinal

1

1 reference

3 August 2017

Martina M Prendergast

series ordinal

2

1 reference

3 August 2017

Edward L Hogan

series ordinal

3

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Journal of the Neurological Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

196

1 reference

3 August 2017

issue

1-2

1 reference

3 August 2017

page(s)

1-7

1 reference

The immunopathogenesis of Miller Fisher syndrome

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Multifocal motor neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Campylobacter jejuni and the expanding spectrum of related infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

An outbreak of presumptive food-borne campylobacter enteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Campylobacter enteritis in the United States. A multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Serotyping of Campylobacter jejuni based on heat-stable antigens: relevance, molecular basis and implications in pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Chemical structure of a polysaccharide from Campylobacter jejuni 176.83 (serotype O:41) containing only furanose sugars

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Specific Serotype of Campylobacter jejuni Associated with Ouillain-Barre Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Chronic thyroiditis and autoimmunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Variants of the Guillain Barré syndrome: progress toward fulfilling "Koch's postulates"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Development of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Multifocal motor neuropathy human sera block distal motor nerve conduction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Passive transfer studies in Guillain-Barré polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Demyelination induced by serum from patients with Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Molecular mimicry in Campylobacter jejuni lipopolysaccharides and the development of Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900036-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00036-9

1 reference

3 August 2017

1 reference